Loading Events

EVENTS

HCLA Annual Home Care Conference 2023

Speaker(s): Melinda A. Gaboury, CEO & Victoria Barron, Clinical Consultant

Category: Conference

  • This event has passed.

Speaker(s): Melinda A. Gaboury, CEO & Victoria Barron, Clinical Consultant

About the Speaker(s)

Melinda A. Gaboury, with more than 30 years in home care, has over 22 years of executive speaking and educating experience, including extensive day to day interaction with home care and hospice professionals. She routinely conducts Home Care and Hospice Reimbursement Workshops and speaks at state association meetings throughout the country.  Melinda has profound experience in Medicare PDGM training, billing, collections, case-mix calculations, chart reviews and due diligence. UPIC, RA, ADR & TPE appeals with all Medicare MACs have become the forefront of Melinda’s current impact on the industry. She is currently serving as the Chair of the NAHC/HHFMA Advisory Board and Work Group and is currently serving on the Board of Directors for both the Home Care Association of Florida & Tennessee Association for Home Care. Melinda is also the author of the Home Health OASIS Guide to OASIS-E  and Home Health Billing Answers, 2023.

Learn More

HCLA Annual Home Care Conference 2023 Oct 26

About the Event

Home Health Medical Review in a Medicare Certified World | October 26 | 8:30 – 9:30am | Melinda A. Gaboury, CEO

This session will take agencies through the deep dark recesses of home health medical review. In light of all the levels of review that are occurring, agencies must be prepared from every angle. The reasons for denial are relatively close, regardless of the reviewer and this session will review the top five and provide a way of avoiding those denials!  Targeted Probe & Educate (TPE) has been fully implemented across the country.  This workshop will allow home health staff members to obtain information in order to evaluate where their agency would stand if TPE comes to their agency today.  Medicare medical review by all contractors was implemented to identify agencies that are being inappropriately reimbursed by Medicare.  The interworkings of this program and how an agency can survive medical review will be addressed.  Directors, clinicians and quality review staff will not want to miss this session. 

  1. Review the different medical review contractors as outlined by CMS
  2. Identify elements that affect the selection of the agency for review
  3. Detail the requirements for successively submitting medical records for review, including appeals

 

Part B Therapy & Home Health  | October 26 | 11:00am – 12:00pm | Melinda A. Gaboury, CEO

This session will review the strategy for identifying patients that are eligible for in-home Part B therapy services.  This session will also cover the documentation requirements for providing this therapy and how the services are reimbursed.  Don’t be confused by the fact that you are a home health agency with a Medicare Part A certification – you are able to bill for this service without being a Medicare Part B certified agency. 

Top 10 Home Health Deficiencies and How to Avoid Them| October 26 | 2:45 – 3:45pm | Victoria Barron, Clinical Consultant

Ongoing survey readiness is key to survey success! This session will cover the top 10 home health survey deficiencies and how to avoid them including tips on documentation, best practices, process implementation, staff training, and survey preparation to ensure your agency is always survey ready.   Guidance on the survey process will be provided to give agencies insight on how the surveyor is going to review the elements related to the Conditions of Participation.  Key elements that surveyors find deficient in agency records will be outlined and reviewed. 

Objectives: 

  • Review Survey Types and Frequency 
  • Discuss All Required Documents for Survey
  • Identify the top 10 home health deficiencies and discuss tips for compliance.  
  • Learn Readiness Tips for Survey Success

Review updated guidance as it relates to home health survey following the conclusion of the PHE.